Description
Baricitinib Tablets
In February 2017, baricitinib was approved for use in the European Union as a second-line therapy for moderate to severe active rheumatoid arthritis in adults, either alone or in combination with methotrexate.
In May 2018, the US Food and Drug Administration (FDA) approved baricitinib for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies.
List Of Generic Brands For Baricitinib Tablets In India
If you are looking generic brands for Baricitinib Tablets in India. Please contact us at +91 9953466646 or drop us an email at sales@aarkpharma.com. Our representatives will be happy to assist you and answer any questions you may have Baricitinib Tablets Price is available at Aark Pharmaceuticals.